Aurobindo Pharma gets UK-MHRA nod for Kazipally facility

New Delhi, Sept 7 (UNI) Aurobindo Pharma Ltd today said it has received GMP Clearance from UK-MHRA for its facility situated at Kazipally, near Hyderabad, completing one of the important formalities of supplies to the European Union and observer states.

The certificate is also recognised by several other regulatory agencies and customers globally, a company statement said, adding that the facility has already been inspected successfully in the past by both USFDA and WHO-Geneva.

Aurobindo's products are spread over six major areas encompassing antibiotics, nnti-retro virals, CVS, CNS, gastroenterologicals, and anti-allergics.

UNI